Two years into the Obama administration and heading into a high-stakes midterm election, the U.S. Chamber of Commerce is in the midst of a multifront war. The business lobby is battling over the legislative response to the BP oil spill, energy and environmental regulation, immigration, and the next stages of the health care and financial regulatory overhauls. Much of the Chamber’s fire is aimed at beating its old nemesis, the plaintiffs bar, which is in the rare position of having a Democratic Congress and White House.
The Chamber has plenty of resources for the fight. Its lobbying tab for the first half of 2010 was roughly $44 million, dwarfing spending by other large business groups. The Pharmaceutical Research and Manufacturers of America, which is the key lobbying organization for drugmakers, spent roughly $11.7 million in the first half of the year, and the American Bankers Association doled out $4.2 million on lobbying. Lobbying by the Chamber’s Institute for Legal Reform made up nearly $9.4 million of the total, and other Chamber lobbyists work on legal issues as well.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
